Skip to main content
Regulation - Spring 2026 - Cover

Spring 2026

Vol. 49 No. 1
From the Cover
Behind the Issue

Unintended Consequences

The Podcast of Regulation
In This Episode

During the covid pandemic, it became popular for folks to say “just follow the science” when it came to making decisions about medical treatment and public health. But in this episode – which covers ivermectin, psychologists’ prescription authority, and warning labels for pediatric anti-depressants – Paul and Peter discuss just how complicated the science can be and why both “just following the science” and “doing your own research” are inadequate responses.


In conjunction with Regulation Spring 2026

Features

Reconsidering Ivermectin

By Charles L. Hooper and David R. Henderson

Despite a skeptical Cochrane review, the antiparasitic is still a valuable tool for combating COVID.

A Tragic Unintended Consequence

By Arif Khan, Anshu Arora, and Aishwarya Prasad

Did adding a “black box” warning to antidepressants lower their usage and increase youth suicides?

Briefly Noted
Oh BOI: Reforming Financial Reporting
By Thomas A. Hemphill

Lengthy federal litigation has attempted to stop the implementation of various BOI requirements, with critics claiming they are overly burdensome, unconstitutional, and raise privacy and data security concerns.

Another Trump Turn from Reaganism
By Art Fraas, Randall Lutter, and W. Kip Viscusi

President Reagan’s Executive Order 12291 in 1981 directed agencies to regulate only if the economic benefits outweigh the costs of such regulation.

There Is No Labor Shortage
By Pierre Lemieux

Despite employer complaints of a labor shortage of trade workers, their high wages simply show they are in demand.

Buried in Bureaucracy
By Alex J. Adams and Adam N. Jones

The administrative costs of federal grants are vast and growing.

Final Word